RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Letrozole
Related studies linked through entity extraction aliases.
Ribociclib and Letrozole Treatment in Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)
- Status
- COMPLETED
- Phase
- PHASE2
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS
- Status
- COMPLETED
- Phase
- PHASE3
Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Endometrial Preparation in Frozen Embryo Transfer Cycles
- Status
- UNKNOWN
- Phase
- NA
Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Intrauterine Insemination With Letrozole Versus in Natural Cycle
- Status
- COMPLETED
- Phase
- NA
Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Different Methods of Termination of Second Trimester Abortion
- Status
- UNKNOWN
- Phase
- NA
IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2